ACH
PRAX icon

ArrowMark Colorado Holdings’s Praxis Precision Medicines PRAX Stock Holding History

ArrowMark Colorado Holdings’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.4M Sell
46,030
-71,821
-61% -$22.7M 0.64% 36
2026
Q1 		$38M Buy
117,851
+87,851
+293% +$27.2M 1.01% 24
2025
Q4 		$8.84M Buy
+30,000
New +$5.59M 0.19% 149

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

ArrowMark Colorado Holdings's PRAX Position: Q2 2026 in Review

ArrowMark Colorado Holdings reduced its Praxis Precision Medicines (PRAX) stake by 61% in Q2 2026, selling an estimated $22.7M and leaving 46,030 shares worth $15.4M. The position accounts for 0.64% of the portfolio, ranked #36.

ArrowMark Colorado Holdings first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. The position peaked at $38M in Q1 2026. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • ArrowMark Colorado Holdings held 46,030 shares of Praxis Precision Medicines worth $15.4M as of Q2 2026.
  • ArrowMark Colorado Holdings sold 71,821 Praxis Precision Medicines shares in Q2 2026, an estimated $22.7M.
  • Praxis Precision Medicines made up 0.64% of ArrowMark Colorado Holdings's portfolio in Q2 2026, its #36 holding.
  • ArrowMark Colorado Holdings first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • ArrowMark Colorado Holdings's Praxis Precision Medicines position peaked at $38M in Q1 2026.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.